The Effect of Statins on Clinical Outcome Among Hospitalized Patients With COVID-19: A Multi-Centric Cohort Study

The coronavirus disease-2019 (COVID-19) is caused by SARS-CoV-2, leading to acute respiratory distress syndrome (ARDS), thrombotic complications, and myocardial injury. Statins, prescribed for lipid reduction, have anti-inflammatory, anti-thrombotic, and immunomodulatory properties and are associate...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Srikanth Umakanthan, Sanjum Senthil, Stanley John, Mahesh K. Madhavan, Jessica Das, Sonal Patil, Raghunath Rameshwaram, Ananya Cintham, Venkatesh Subramaniam, Madhusudan Yogi, Abhishek Bansal, Sumesh Achutham, Chandini Shekar, Vijay Murthy, Robbin Selvaraj
Format:	Artigo
Język:	Inglês
Wydane:	Frontiers Media S.A. 2022-07-01
Seria:	Frontiers in Pharmacology
Hasła przedmiotowe:	COVID-19 statins cohort mortality propensity
Dostęp online:	https://www.frontiersin.org/articles/10.3389/fphar.2022.742273/full
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!